TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital
US Patent
The General Hospital
US Patent
Affinity DataIC50: >2.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair